Brolucizumab Treatment Experience Study of Patients With nAMD in UK Routine Clinical Practice
NCT05112835
·
clinicaltrials.gov ↗
TERMINATED
Status
302
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decision
Conditions
Neovascular Age-related Macular Degeneration
Interventions
OTHER:
brolucizumab
Sponsor
Novartis Pharmaceuticals